Cargando…
The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers
Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943440/ https://www.ncbi.nlm.nih.gov/pubmed/35371741 http://dx.doi.org/10.7759/cureus.22474 |
_version_ | 1784673517925564416 |
---|---|
author | Kunioka, Shingo Shirasaka, Tomonori Miyamoto, Hiroyuki Shibagaki, Keisuke Kikuchi, Yuta Akasaka, Nobuyuki Kamiya, Hiroyuki |
author_facet | Kunioka, Shingo Shirasaka, Tomonori Miyamoto, Hiroyuki Shibagaki, Keisuke Kikuchi, Yuta Akasaka, Nobuyuki Kamiya, Hiroyuki |
author_sort | Kunioka, Shingo |
collection | PubMed |
description | Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especially in high-volume centers. In this study, we investigated the effectiveness of earlier initiation of VA-ECMO for PCS in low-volume centers. Methods We retrospectively assessed patients admitted in two of our related facilities from April 2014 to March 2019. The patients who underwent VA-ECMO during peri- or post-cardiac surgery (within 48 hours) were included. We divided the patients into two groups according to the timing of VA-ECMO initiation. In the early initiation of VA-ECMO group, the “early ECMO group,” VA-ECMO was initiated when patients needed high-dose inotropic support with high-dose catecholamines, such as epinephrine, without waiting for PCS recovery. In the late initiation of VA-ECMO group, the “late ECMO group,” VA-ECMO was delayed until PCS was not controlled with high-dose catecholamines, with the intent of avoiding severe bleeding complications. Results A total of 30 patients were included in the analysis (early ECMO group/late ECMO group: 19/11 patients). Thirty-day mortality in the entire cohort was 60% (n=18), and there was no significant difference between the two groups (early ECMO group/late ECMO group: 64%/55%, p=0.712). Thirteen and six patients died without being weaned off in the early ECMO (43%) and late ECMO groups (55%), respectively; there was no significant difference between the two groups (p=0.696). The median duration of ECMO support was five days (IQR: 1.5-6.5). Conclusions The early initiation of ECMO did not contribute to patients’ 30-day outcomes in low-volume centers. To improve outcomes of ECMO therapy in patients with PCS, centralization of low-volume centers may be required. |
format | Online Article Text |
id | pubmed-8943440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89434402022-04-01 The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers Kunioka, Shingo Shirasaka, Tomonori Miyamoto, Hiroyuki Shibagaki, Keisuke Kikuchi, Yuta Akasaka, Nobuyuki Kamiya, Hiroyuki Cureus Cardiac/Thoracic/Vascular Surgery Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especially in high-volume centers. In this study, we investigated the effectiveness of earlier initiation of VA-ECMO for PCS in low-volume centers. Methods We retrospectively assessed patients admitted in two of our related facilities from April 2014 to March 2019. The patients who underwent VA-ECMO during peri- or post-cardiac surgery (within 48 hours) were included. We divided the patients into two groups according to the timing of VA-ECMO initiation. In the early initiation of VA-ECMO group, the “early ECMO group,” VA-ECMO was initiated when patients needed high-dose inotropic support with high-dose catecholamines, such as epinephrine, without waiting for PCS recovery. In the late initiation of VA-ECMO group, the “late ECMO group,” VA-ECMO was delayed until PCS was not controlled with high-dose catecholamines, with the intent of avoiding severe bleeding complications. Results A total of 30 patients were included in the analysis (early ECMO group/late ECMO group: 19/11 patients). Thirty-day mortality in the entire cohort was 60% (n=18), and there was no significant difference between the two groups (early ECMO group/late ECMO group: 64%/55%, p=0.712). Thirteen and six patients died without being weaned off in the early ECMO (43%) and late ECMO groups (55%), respectively; there was no significant difference between the two groups (p=0.696). The median duration of ECMO support was five days (IQR: 1.5-6.5). Conclusions The early initiation of ECMO did not contribute to patients’ 30-day outcomes in low-volume centers. To improve outcomes of ECMO therapy in patients with PCS, centralization of low-volume centers may be required. Cureus 2022-02-21 /pmc/articles/PMC8943440/ /pubmed/35371741 http://dx.doi.org/10.7759/cureus.22474 Text en Copyright © 2022, Kunioka et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiac/Thoracic/Vascular Surgery Kunioka, Shingo Shirasaka, Tomonori Miyamoto, Hiroyuki Shibagaki, Keisuke Kikuchi, Yuta Akasaka, Nobuyuki Kamiya, Hiroyuki The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers |
title | The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers |
title_full | The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers |
title_fullStr | The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers |
title_full_unstemmed | The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers |
title_short | The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers |
title_sort | early introduction of extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock does not improve 30-day mortality rates in low-volume centers |
topic | Cardiac/Thoracic/Vascular Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943440/ https://www.ncbi.nlm.nih.gov/pubmed/35371741 http://dx.doi.org/10.7759/cureus.22474 |
work_keys_str_mv | AT kuniokashingo theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT shirasakatomonori theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT miyamotohiroyuki theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT shibagakikeisuke theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT kikuchiyuta theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT akasakanobuyuki theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT kamiyahiroyuki theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT kuniokashingo earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT shirasakatomonori earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT miyamotohiroyuki earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT shibagakikeisuke earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT kikuchiyuta earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT akasakanobuyuki earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters AT kamiyahiroyuki earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters |